United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-528_d3f9b554-05be-484f-b9e7-5c8e6b2de9c9
- Product NDC
- 65862-528
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110601
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-01) · 65862-528-01
- 10 BLISTER PACK in 1 CARTON (65862-528-10) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK · 65862-528-10
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-30) · 65862-528-30
- 3500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-35) · 65862-528-35
- 15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-47) · 65862-528-47
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-90) · 65862-528-90
- 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-528-99) · 65862-528-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →